Gill Bowden leads commercial, performance marketing and strategic consulting teams at Evinova, the AI-enabled digital health business spun out of AstraZeneca. From a standing start, she has built multi-year enterprise partnerships with four of the top five global CROs and multiple top-ten pharma sponsors, with digital capabilities embedded directly into how trials are designed, optimized and delivered rather than bolted on as a vendor service. Her near three-decade career spans clinical development, digital health and AI, including early years in trial operations at multinational CROs and helping scale a decentralised clinical trials platform from a $100 million Series A start-up to a $2.3 billion unicorn. Having sat on both sides of the sponsor–provider relationship, Gill brings a practitioner’s view of what it takes to move from transactional contracts to shared accountability for trial outcomes, and to turn digital innovation into scaled, commercially sustainable impact for sponsors, sites and patients.